# Trimodality Therapy for Malignant Pleural Mesothelioma

> **NCT01343264** · — · UNKNOWN · sponsor: **HSK Wiesbaden** · enrollment: 200 (estimated)

## Conditions studied

- Malignant Pleural Mesothelioma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01343264
- **Lead sponsor:** HSK Wiesbaden
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-11
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01343264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01343264, "Trimodality Therapy for Malignant Pleural Mesothelioma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01343264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
